Dominik Schieman joined Novartis in 2020 and holds a position as Expert Science & Technology. In his current role, he specializes in investigating new cell retention setups for dynamic perfusion cell cultures. His primary focus is to enhance the product sieving and overall yield of upstream processes. Within his interdisciplinary group at Novartis, he drives innovation for future processes. He received is MSc in Biotechnology at the ETH Zurich.
Discover insights from other experts